<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en">
	<id>https://wikem.org/w/api.php?action=feedcontributions&amp;feedformat=atom&amp;user=Epae</id>
	<title>WikEM - User contributions [en]</title>
	<link rel="self" type="application/atom+xml" href="https://wikem.org/w/api.php?action=feedcontributions&amp;feedformat=atom&amp;user=Epae"/>
	<link rel="alternate" type="text/html" href="https://wikem.org/wiki/Special:Contributions/Epae"/>
	<updated>2026-04-22T22:53:42Z</updated>
	<subtitle>User contributions</subtitle>
	<generator>MediaWiki 1.38.2</generator>
	<entry>
		<id>https://wikem.org/w/index.php?title=Digoxin_toxicity&amp;diff=10527</id>
		<title>Digoxin toxicity</title>
		<link rel="alternate" type="text/html" href="https://wikem.org/w/index.php?title=Digoxin_toxicity&amp;diff=10527"/>
		<updated>2012-11-14T00:25:09Z</updated>

		<summary type="html">&lt;p&gt;Epae: /* Risk Factors */&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;== Background ==&lt;br /&gt;
*Mechanism of action&lt;br /&gt;
**Positive inotropic effect&lt;br /&gt;
***Inhibits Na-K pump -&amp;gt; incr extracelluar K, incr intracellular Na -&amp;gt; incr intracellular Ca&lt;br /&gt;
**Increases vagal tone&lt;br /&gt;
***Can lead to bradyarrhythmias (esp in young)&lt;br /&gt;
**Increases automaticity&lt;br /&gt;
***Can lead to tachyarrhythmias (esp in elderly)&lt;br /&gt;
*Renally cleared&lt;br /&gt;
*Hemodialysis does not work&lt;br /&gt;
&lt;br /&gt;
=== Risk Factors  ===&lt;br /&gt;
&lt;br /&gt;
#Electrolyte Imbalance &lt;br /&gt;
##[[Hypokalemia|Hyperkalemia]], [[Hypomagnesemia]], [[Hypercalcemia]] &lt;br /&gt;
#Hypovolemia &lt;br /&gt;
#Renal insufficiency &lt;br /&gt;
#[[Cardiac Ischemia]] &lt;br /&gt;
#[[Hypothyroidism]] &lt;br /&gt;
#Meds &lt;br /&gt;
##CCBs, amiodarone&lt;br /&gt;
&lt;br /&gt;
== Clinical Manifestations ==&lt;br /&gt;
===Cardiac===&lt;br /&gt;
#[[Syncope]]&lt;br /&gt;
#Dysrhythmias&lt;br /&gt;
##PVCs&lt;br /&gt;
##[[Bradycardia]]&lt;br /&gt;
##SVT w/ AV block&lt;br /&gt;
##Junctional escape&lt;br /&gt;
##Ventricular dysrhythmia, including bidirectional V-tach (esp in chronic toxicity)&lt;br /&gt;
#Digitalis Effect (seen with therapeutic levels; not indicative of toxicity)&lt;br /&gt;
##T wave changes (flattening or inversion)&lt;br /&gt;
##QT interval shortening&lt;br /&gt;
##Scooped ST segments with depression in lateral leads&lt;br /&gt;
##Increased U-wave amplitude&lt;br /&gt;
&lt;br /&gt;
===GI===&lt;br /&gt;
#Often the earliest manifestation of toxicity&lt;br /&gt;
##[[Nausea/vomiting]]&lt;br /&gt;
##[[Abdominal Pain]]&lt;br /&gt;
&lt;br /&gt;
===Neuro===&lt;br /&gt;
#[[Confusion]]&lt;br /&gt;
#[[Weakness]]&lt;br /&gt;
#Visual disturbances&lt;br /&gt;
##Yellow halos&lt;br /&gt;
##Scotomas&lt;br /&gt;
#Delirium&lt;br /&gt;
&lt;br /&gt;
==Work-Up==&lt;br /&gt;
#Dig level&lt;br /&gt;
##Only useful prior to administration of [[Fab]] (otherwise becomes falsely elevated)&lt;br /&gt;
#Chemistry&lt;br /&gt;
#Urine output&lt;br /&gt;
#ECG (serial)&lt;br /&gt;
&lt;br /&gt;
== Diagnosis ==&lt;br /&gt;
#Must use H&amp;amp;P and labs in combination; no single element excludes or confirms the dx&lt;br /&gt;
#Digoxin level&lt;br /&gt;
##Normal = 0.5-2 ng/mL (ideal = 0.7-1.1)&lt;br /&gt;
###May have toxicity even with &amp;quot;therapeutic&amp;quot; levels (esp w/ chronic toxicity)&lt;br /&gt;
##Measure at least 6hr after acute ingestion (if stable); immediately for chronic ingestion&lt;br /&gt;
###If measure before this may be falsely elevated due to incomplete drug distribution&lt;br /&gt;
#Potassium level&lt;br /&gt;
##Acute toxicity: Degree of [[Hyperkalemia]] correlates w/ degree of toxicity&lt;br /&gt;
##Chronic toxicity: K+ may be normal/low (concomitant diuretic use) or high (renal failure)&lt;br /&gt;
&lt;br /&gt;
==DDX==&lt;br /&gt;
#CCB/BB toxicity&lt;br /&gt;
#Clonidine toxicity&lt;br /&gt;
#[[Organophosphate Toxicity]]&lt;br /&gt;
#Sick sinus syndrome&lt;br /&gt;
&lt;br /&gt;
== Treatment ==&lt;br /&gt;
#'''[[Digoxin Immune Fab]]'''&lt;br /&gt;
#[[Activated Charcoal]]&lt;br /&gt;
##Questionable efficacy&lt;br /&gt;
##Only an adjunctive tx; NOT an alternative to fab fragment therapy&lt;br /&gt;
##Consider only if present within 1 hr of ingestion&lt;br /&gt;
##1g/kg (max 50g)&lt;br /&gt;
&lt;br /&gt;
===Dysrhythmias===&lt;br /&gt;
#[[Digoxin Immune Fab]] is the agent of choice for all dysrhythmias!&lt;br /&gt;
#[[Cardioversion]] should only be used as a last resort (may precipitate V-Fib)&lt;br /&gt;
##Consider lower energy settings (25-50J) &lt;br /&gt;
#Bradyarrhythmias (symptomatic)&lt;br /&gt;
##[[Atropine]] 0.5mg IV&lt;br /&gt;
##[[Pacing]]&lt;br /&gt;
#Ventricular dysrhythmias&lt;br /&gt;
##[[Dilantin Load|Phenytoin]]&lt;br /&gt;
###Enhances AV conduction&lt;br /&gt;
###Phenytoin: 15-20mg/kg at 50mg/min&lt;br /&gt;
###Fosphenytoin: 15-20mg PE/kg at 100-150mg/min&lt;br /&gt;
##[[Lidocaine]]&lt;br /&gt;
###Decreases ventricular automaticity&lt;br /&gt;
###1-3mg/kg over several minutes; follow by 1-4mg/min&lt;br /&gt;
&lt;br /&gt;
===[[Hyperkalemia]]===&lt;br /&gt;
#Treat with [[Fab]], not with usual meds&lt;br /&gt;
##Once Fab is given hyperkalemia will rapidly correct&lt;br /&gt;
#If [[Fab]] unavailable and hyperkalemia is life-threatening then treat with:&lt;br /&gt;
##Glucose-insulin&lt;br /&gt;
##Sodium bicarb&lt;br /&gt;
##Kayexelate&lt;br /&gt;
##Dialysis&lt;br /&gt;
##Calcium (controversial: some say dangerous, others say not)&lt;br /&gt;
&lt;br /&gt;
===[[Hypokalemia]]===&lt;br /&gt;
#Chronic intoxication&lt;br /&gt;
##Raise level to 3.5-4&lt;br /&gt;
#Acute intoxication&lt;br /&gt;
##Do not treat (likely that potassium level is rapidly rising)&lt;br /&gt;
&lt;br /&gt;
===[[Hypomagnesemia]]===&lt;br /&gt;
#Treat with 1-2g over 10-20 min&lt;br /&gt;
##Monitor for resp depresion&lt;br /&gt;
##Avoid in pts with:&lt;br /&gt;
###Renal failure&lt;br /&gt;
###Bradydysrhythmias/conduction blocks&lt;br /&gt;
&lt;br /&gt;
==Disposition==&lt;br /&gt;
*Admit for signs of toxicity or history of large ingested dose; admit to ICU if [[Fab]] given&lt;br /&gt;
*Discharge after 12hr observation if asymptomatic after accidental overdose&lt;br /&gt;
&lt;br /&gt;
==See Also==&lt;br /&gt;
*[[Digoxin Immune Fab]]&lt;br /&gt;
*[[Toxidromes]]&lt;br /&gt;
*[[Digoxin]]&lt;br /&gt;
&lt;br /&gt;
== Source ==&lt;br /&gt;
*Rosen's&lt;br /&gt;
*Tintinalli&lt;br /&gt;
&lt;br /&gt;
[[Category:Cards]]&lt;br /&gt;
[[Category:Drugs]]&lt;br /&gt;
[[Category:Tox]]&lt;/div&gt;</summary>
		<author><name>Epae</name></author>
	</entry>
	<entry>
		<id>https://wikem.org/w/index.php?title=Parkinson%27s_disease&amp;diff=10521</id>
		<title>Parkinson's disease</title>
		<link rel="alternate" type="text/html" href="https://wikem.org/w/index.php?title=Parkinson%27s_disease&amp;diff=10521"/>
		<updated>2012-11-05T19:58:33Z</updated>

		<summary type="html">&lt;p&gt;Epae: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;==Background==&lt;br /&gt;
*Extrapyramidal movement disorder a/w reduced dopaminergic receptors in substantia nigra&lt;br /&gt;
&lt;br /&gt;
==Clinical Features==&lt;br /&gt;
*TRAP mnemonic:&lt;br /&gt;
**Tremor (resting)&lt;br /&gt;
***Initially is unilateral tremor of upper extremity, esp finger and thumb (&amp;quot;pill rolling&amp;quot;)&lt;br /&gt;
***Dissipates when intentional movement is performed&lt;br /&gt;
**Rigidity (cogwheel)&lt;br /&gt;
***Elicited by causing passive movement of limb through full range of motion&lt;br /&gt;
**Akinesia&lt;br /&gt;
***Slowness of voluntary movement&lt;br /&gt;
**Posture/equilibrium impairment&lt;br /&gt;
***Impaired ability to turn or change direction while walking&lt;br /&gt;
&lt;br /&gt;
== Treatmenthttp://www.wikem.org/w/index.php?title=Parkinson%27s_Disease&amp;amp;amp;action=edit&amp;amp;amp;section=&amp;lt;br&amp;gt; ==&lt;br /&gt;
&lt;br /&gt;
*Dopamine agonists &amp;lt;br&amp;gt;&lt;br /&gt;
**Levodopa&amp;amp;nbsp; +Carbidopa (peripheral decarboxylase inhibitor) = gold standard&amp;lt;br&amp;gt;&lt;br /&gt;
**pramipexole (Mirapex)&amp;lt;br&amp;gt;ropinirole (Requip)&amp;lt;br&amp;gt;&lt;br /&gt;
*Anticholenergics&amp;lt;br&amp;gt;&lt;br /&gt;
**Benztropine&amp;lt;br&amp;gt;&lt;br /&gt;
*Monoamine oxidase inhibitor - blocks DA reuptake&amp;lt;br&amp;gt; &lt;br /&gt;
**selegiline (Eldepryl)&amp;lt;br&amp;gt; &lt;br /&gt;
**rasagiline (Azilect)&amp;lt;br&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&amp;lt;br&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Source==&lt;br /&gt;
Tintinalli&lt;br /&gt;
&lt;br /&gt;
[[Category:Neuro]]&lt;/div&gt;</summary>
		<author><name>Epae</name></author>
	</entry>
	<entry>
		<id>https://wikem.org/w/index.php?title=Parkinson%27s_disease&amp;diff=10520</id>
		<title>Parkinson's disease</title>
		<link rel="alternate" type="text/html" href="https://wikem.org/w/index.php?title=Parkinson%27s_disease&amp;diff=10520"/>
		<updated>2012-11-05T19:51:54Z</updated>

		<summary type="html">&lt;p&gt;Epae: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;==Background==&lt;br /&gt;
*Extrapyramidal movement disorder a/w reduced dopaminergic receptors in substantia nigra&lt;br /&gt;
&lt;br /&gt;
==Clinical Features==&lt;br /&gt;
*TRAP mnemonic:&lt;br /&gt;
**Tremor (resting)&lt;br /&gt;
***Initially is unilateral tremor of upper extremity, esp finger and thumb (&amp;quot;pill rolling&amp;quot;)&lt;br /&gt;
***Dissipates when intentional movement is performed&lt;br /&gt;
**Rigidity (cogwheel)&lt;br /&gt;
***Elicited by causing passive movement of limb through full range of motion&lt;br /&gt;
**Akinesia&lt;br /&gt;
***Slowness of voluntary movement&lt;br /&gt;
**Posture/equilibrium impairment&lt;br /&gt;
***Impaired ability to turn or change direction while walking&lt;br /&gt;
&lt;br /&gt;
== Treatmenthttp://www.wikem.org/w/index.php?title=Parkinson%27s_Disease&amp;amp;amp;action=edit&amp;amp;amp;section=3 ==&lt;br /&gt;
&lt;br /&gt;
*Anticholinergics &lt;br /&gt;
**Benztropine &lt;br /&gt;
*Dopamine agonists &lt;br /&gt;
**Levodopa/ Carbidopa&amp;lt;br&amp;gt;&lt;br /&gt;
**pramipexole (Mirapex) &amp;lt;br&amp;gt;ropinirole (Requip)&amp;lt;br&amp;gt; &lt;br /&gt;
*Monoamine oxidase inhibitor - blocks DA reuptake&amp;lt;br&amp;gt;&lt;br /&gt;
**selegiline (Eldepryl)&amp;lt;br&amp;gt;&lt;br /&gt;
**rasagiline (Azilect)&amp;lt;br&amp;gt;&lt;br /&gt;
**Bromocriptine&lt;br /&gt;
&lt;br /&gt;
==Source==&lt;br /&gt;
Tintinalli&lt;br /&gt;
&lt;br /&gt;
[[Category:Neuro]]&lt;/div&gt;</summary>
		<author><name>Epae</name></author>
	</entry>
	<entry>
		<id>https://wikem.org/w/index.php?title=Parkinson%27s_disease&amp;diff=10519</id>
		<title>Parkinson's disease</title>
		<link rel="alternate" type="text/html" href="https://wikem.org/w/index.php?title=Parkinson%27s_disease&amp;diff=10519"/>
		<updated>2012-11-05T19:47:45Z</updated>

		<summary type="html">&lt;p&gt;Epae: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;==Background==&lt;br /&gt;
*Extrapyramidal movement disorder a/w reduced dopaminergic receptors in substantia nigra&lt;br /&gt;
&lt;br /&gt;
==Clinical Features==&lt;br /&gt;
*TRAP mnemonic:&lt;br /&gt;
**Tremor (resting)&lt;br /&gt;
***Initially is unilateral tremor of upper extremity, esp finger and thumb (&amp;quot;pill rolling&amp;quot;)&lt;br /&gt;
***Dissipates when intentional movement is performed&lt;br /&gt;
**Rigidity (cogwheel)&lt;br /&gt;
***Elicited by causing passive movement of limb through full range of motion&lt;br /&gt;
**Akinesia&lt;br /&gt;
***Slowness of voluntary movement&lt;br /&gt;
**Posture/equilibrium impairment&lt;br /&gt;
***Impaired ability to turn or change direction while walking&lt;br /&gt;
&lt;br /&gt;
== Treatment ==&lt;br /&gt;
&lt;br /&gt;
*Anticholinergics &lt;br /&gt;
**Benztropine &lt;br /&gt;
*Dopamine agonists &lt;br /&gt;
**Levodopa &lt;br /&gt;
**Bromocriptine&lt;br /&gt;
&lt;br /&gt;
==Source==&lt;br /&gt;
Tintinalli&lt;br /&gt;
&lt;br /&gt;
[[Category:Neuro]]&lt;/div&gt;</summary>
		<author><name>Epae</name></author>
	</entry>
	<entry>
		<id>https://wikem.org/w/index.php?title=Phenytoin_toxicity&amp;diff=10518</id>
		<title>Phenytoin toxicity</title>
		<link rel="alternate" type="text/html" href="https://wikem.org/w/index.php?title=Phenytoin_toxicity&amp;diff=10518"/>
		<updated>2012-11-05T19:43:16Z</updated>

		<summary type="html">&lt;p&gt;Epae: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;== Background ==&lt;br /&gt;
&lt;br /&gt;
*Mortality is extremely rare after intentional overdose if good supportive care is provided &lt;br /&gt;
*Rapid IV dosing carries greatest risk (due to propylene glycol constituent of IV form --&amp;amp;gt; myocardia depression &amp;amp;amp; cardiac arrest) &lt;br /&gt;
*90% protein bound; dialysis ineffective&lt;br /&gt;
&lt;br /&gt;
== Clinical Features ==&lt;br /&gt;
&lt;br /&gt;
*CV (only with IV form) &lt;br /&gt;
**Bradycardia &lt;br /&gt;
**Hypotension &lt;br /&gt;
**Asystole&lt;br /&gt;
*Neuro &lt;br /&gt;
**Nystagmus &lt;br /&gt;
***First only with forced lateral gaze; later becomes spontaneous &lt;br /&gt;
***May disappear at higher levels&lt;br /&gt;
**Ataxia &lt;br /&gt;
**Decreased LOC&lt;br /&gt;
*GI &lt;br /&gt;
**N/V&lt;br /&gt;
*Skin&lt;br /&gt;
**tissue infiltration (IV) --&amp;amp;gt; &amp;quot;purple glove syndrome&amp;quot; &lt;br /&gt;
**edema, pain, ischemia, tissue necrosis, compartment syndrome&lt;br /&gt;
&lt;br /&gt;
&amp;lt;br&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Diagnosis==&lt;br /&gt;
*Phenytoin level&lt;br /&gt;
**Provides a rough guide only; neither sensitive nor specific&lt;br /&gt;
**Level &amp;gt;10: usually no symptoms&lt;br /&gt;
**Level 10-20: Occasional mild nystagmus&lt;br /&gt;
**Level 20-30: Nystagmus&lt;br /&gt;
**Level 30-40: Ataxia, slurred speech, N/V&lt;br /&gt;
**Level 40-50: Lethargy, confusion&lt;br /&gt;
**Level &amp;gt;50: Coma, seizure (rare)&lt;br /&gt;
&lt;br /&gt;
==Treatment==&lt;br /&gt;
#Detoxification&lt;br /&gt;
##Activated charcoal PO&lt;br /&gt;
#Bradyarrhythmias&lt;br /&gt;
##Atropine, pacing&lt;br /&gt;
#Hypotension&lt;br /&gt;
##IVF&lt;br /&gt;
&lt;br /&gt;
==Disposition==&lt;br /&gt;
*Cannot base on phenytoin level (erratic absorption after PO overdose)&lt;br /&gt;
**Consider discharge if pt has only mild symptoms and serial phenytoin levels decline&lt;br /&gt;
&lt;br /&gt;
==Source==&lt;br /&gt;
Tintinalli&lt;br /&gt;
&lt;br /&gt;
[[Category:Tox]]&lt;/div&gt;</summary>
		<author><name>Epae</name></author>
	</entry>
	<entry>
		<id>https://wikem.org/w/index.php?title=Phenytoin_toxicity&amp;diff=10517</id>
		<title>Phenytoin toxicity</title>
		<link rel="alternate" type="text/html" href="https://wikem.org/w/index.php?title=Phenytoin_toxicity&amp;diff=10517"/>
		<updated>2012-11-05T19:40:54Z</updated>

		<summary type="html">&lt;p&gt;Epae: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;== Background ==&lt;br /&gt;
&lt;br /&gt;
*Mortality is extremely rare after intentional overdose if good supportive care is provided &lt;br /&gt;
*Rapid IV dosing carries greatest risk (due to propylene glycol constituent of IV form --&amp;amp;gt; myocardia depression &amp;amp;amp; cardiac arrest) &lt;br /&gt;
*90% protein bound; dialysis ineffective&lt;br /&gt;
&lt;br /&gt;
==Clinical Features==&lt;br /&gt;
*CV (only with IV form)&lt;br /&gt;
**Bradycardia&lt;br /&gt;
**Hypotension&lt;br /&gt;
**Asystole&lt;br /&gt;
*Neuro&lt;br /&gt;
**Nystagmus&lt;br /&gt;
***First only with forced lateral gaze; later becomes spontaneous&lt;br /&gt;
***May disappear at higher levels&lt;br /&gt;
**Ataxia&lt;br /&gt;
**Decreased LOC&lt;br /&gt;
*GI&lt;br /&gt;
**N/V&lt;br /&gt;
&lt;br /&gt;
==Diagnosis==&lt;br /&gt;
*Phenytoin level&lt;br /&gt;
**Provides a rough guide only; neither sensitive nor specific&lt;br /&gt;
**Level &amp;gt;10: usually no symptoms&lt;br /&gt;
**Level 10-20: Occasional mild nystagmus&lt;br /&gt;
**Level 20-30: Nystagmus&lt;br /&gt;
**Level 30-40: Ataxia, slurred speech, N/V&lt;br /&gt;
**Level 40-50: Lethargy, confusion&lt;br /&gt;
**Level &amp;gt;50: Coma, seizure (rare)&lt;br /&gt;
&lt;br /&gt;
==Treatment==&lt;br /&gt;
#Detoxification&lt;br /&gt;
##Activated charcoal PO&lt;br /&gt;
#Bradyarrhythmias&lt;br /&gt;
##Atropine, pacing&lt;br /&gt;
#Hypotension&lt;br /&gt;
##IVF&lt;br /&gt;
&lt;br /&gt;
==Disposition==&lt;br /&gt;
*Cannot base on phenytoin level (erratic absorption after PO overdose)&lt;br /&gt;
**Consider discharge if pt has only mild symptoms and serial phenytoin levels decline&lt;br /&gt;
&lt;br /&gt;
==Source==&lt;br /&gt;
Tintinalli&lt;br /&gt;
&lt;br /&gt;
[[Category:Tox]]&lt;/div&gt;</summary>
		<author><name>Epae</name></author>
	</entry>
	<entry>
		<id>https://wikem.org/w/index.php?title=Carbamazepine_toxicity&amp;diff=10516</id>
		<title>Carbamazepine toxicity</title>
		<link rel="alternate" type="text/html" href="https://wikem.org/w/index.php?title=Carbamazepine_toxicity&amp;diff=10516"/>
		<updated>2012-11-05T19:38:06Z</updated>

		<summary type="html">&lt;p&gt;Epae: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;==Background==&lt;br /&gt;
*Has anticholinergic in addition to antiepileptic effects&lt;br /&gt;
*Therapeutic concentration: 4-12&lt;br /&gt;
&lt;br /&gt;
== Clinical Features ==&lt;br /&gt;
&lt;br /&gt;
*May be delayed and follow crescendo-decrescendo course (due to delayed GI motility) &lt;br /&gt;
*CNS &lt;br /&gt;
**Ataxia &lt;br /&gt;
**Nystagmus &lt;br /&gt;
**Coma &lt;br /&gt;
*Anticholinergic toxidrome &lt;br /&gt;
*CV &lt;br /&gt;
**Dysrhythmias are rare but may occur &lt;br /&gt;
**Widened QRS &lt;br /&gt;
**QT prolongation&lt;br /&gt;
&lt;br /&gt;
==Diagnosis==&lt;br /&gt;
*Levels do not accurately correlate w/ clinical severity&lt;br /&gt;
&lt;br /&gt;
==Treatrment==&lt;br /&gt;
*GI detox&lt;br /&gt;
**Activated charcoal (if presents w/in 1hr of ingestion)&lt;br /&gt;
*Dialysis is effective (if needed)&lt;br /&gt;
&lt;br /&gt;
==Disposition==&lt;br /&gt;
*Consider d/c for pt with decreasing levels (measured few hrs apart) and is asymptomatic&lt;br /&gt;
&lt;br /&gt;
==Source==&lt;br /&gt;
*Tintinalli&lt;br /&gt;
&lt;br /&gt;
[[Category:Tox]]&lt;/div&gt;</summary>
		<author><name>Epae</name></author>
	</entry>
	<entry>
		<id>https://wikem.org/w/index.php?title=Organophosphate_toxicity&amp;diff=10515</id>
		<title>Organophosphate toxicity</title>
		<link rel="alternate" type="text/html" href="https://wikem.org/w/index.php?title=Organophosphate_toxicity&amp;diff=10515"/>
		<updated>2012-11-05T19:24:56Z</updated>

		<summary type="html">&lt;p&gt;Epae: /* Clinical Features */&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;==Background==&lt;br /&gt;
*Irreversibly binds acetylcholinesterase -&amp;gt; cholinergic crisis&lt;br /&gt;
*Used as insecticides (malathion) and chemical warfare (sarin, VX)&lt;br /&gt;
*Consider in ddx of pt w/ AMS + miotic pupils&lt;br /&gt;
&lt;br /&gt;
==Clinical Features==&lt;br /&gt;
#SLUDGE(MM)&lt;br /&gt;
##Salivation, lacrimation, urination, diarrhea, GI pain, emesis, miosis, muscle weakness&lt;br /&gt;
#Killers B's&lt;br /&gt;
##Bradycardia, bronchorrhea, bronchospasm&lt;br /&gt;
&lt;br /&gt;
==Diagnosis==&lt;br /&gt;
*CBC&lt;br /&gt;
**May show leukocytosis&lt;br /&gt;
*Lipase&lt;br /&gt;
*LFT&lt;br /&gt;
*CXR&lt;br /&gt;
**Pulmonary edema in severe cases&lt;br /&gt;
*ECG&lt;br /&gt;
**Ventricular dysrhytmias, torsades, QT prolongation, AV block&lt;br /&gt;
&lt;br /&gt;
== Treatment ==&lt;br /&gt;
#Protection&lt;br /&gt;
##Wear protective clothing to prevent secondary poisoning&lt;br /&gt;
##Use neoprene or nitrile gloves (not latex)&lt;br /&gt;
#Decontamination&lt;br /&gt;
##Dispose of all clothes&lt;br /&gt;
##Wash pt with soap/water&lt;br /&gt;
#Airway&lt;br /&gt;
##Suction as needed&lt;br /&gt;
##Intubation if needed d/t respiratory secretions / bronchospasm&lt;br /&gt;
###Use nondepolarizing agent&lt;br /&gt;
#Breathing&lt;br /&gt;
##Use O2 100% NRB&lt;br /&gt;
#Antidotes&lt;br /&gt;
##Atropine&lt;br /&gt;
###May require massive dosage (hundreds of milligrams)&lt;br /&gt;
###Does not reverse muscle weakness&lt;br /&gt;
###Dosing&lt;br /&gt;
####Adult: 1mg or more IV; repeat q5min until tracheobronchial secretions attenuate&lt;br /&gt;
####Child: 0.01-0.04mg/kg (but never &amp;lt;0.1mg) IV&lt;br /&gt;
##Pralidoxime&lt;br /&gt;
###Displaces organophosphate from acetylcholinesterase (if given early)&lt;br /&gt;
###Dosing&lt;br /&gt;
####Adult: 1-2gm IV over 5-10min; continuous infusion of 500mg/hr if no initial response&lt;br /&gt;
####Child: 20-40mg/kg (up to 1gm) IV over 5-10min; 5-10mg/kg/hr if no initial response&lt;br /&gt;
&lt;br /&gt;
==Disposition==&lt;br /&gt;
*Minimal exposure only requires decon and 6-8hr obs&lt;br /&gt;
&lt;br /&gt;
==See Also==&lt;br /&gt;
[[Toxidromes]]&lt;br /&gt;
&lt;br /&gt;
==Source==&lt;br /&gt;
*Tintinalli&lt;br /&gt;
&lt;br /&gt;
[[Category:Tox]]&lt;/div&gt;</summary>
		<author><name>Epae</name></author>
	</entry>
	<entry>
		<id>https://wikem.org/w/index.php?title=Immune_thrombocytopenic_purpura&amp;diff=9682</id>
		<title>Immune thrombocytopenic purpura</title>
		<link rel="alternate" type="text/html" href="https://wikem.org/w/index.php?title=Immune_thrombocytopenic_purpura&amp;diff=9682"/>
		<updated>2012-05-13T00:29:38Z</updated>

		<summary type="html">&lt;p&gt;Epae: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;==Background==&lt;br /&gt;
*Acquired autoimmune disease resulting in destruction of platelets&lt;br /&gt;
*Because circulating plts are functional, life-threatening bleeding only once plt &amp;lt;10K&lt;br /&gt;
*Types&lt;br /&gt;
**Acute&lt;br /&gt;
***More common among younger children&lt;br /&gt;
***Affects men/women equally&lt;br /&gt;
***Resolves in 1-2mo&lt;br /&gt;
**Chronic&lt;br /&gt;
***Lasts &amp;gt;3mo&lt;br /&gt;
***More common in adults and women&lt;br /&gt;
***Rarely remits spontaneously or with tx&lt;br /&gt;
***More likely to have an ynderlying disease or autoimmune disorder (e.g. SLE)&lt;br /&gt;
&lt;br /&gt;
==Clinical Features==&lt;br /&gt;
*Petechiae&lt;br /&gt;
*Epistaxis, ginigival bleeding, menorrhagia&lt;br /&gt;
&lt;br /&gt;
==Diagnosis==&lt;br /&gt;
*Diagnosis of exclusion&lt;br /&gt;
**Must differentiate from chronic ITP, which suggests an underlying disorder&lt;br /&gt;
*CBC shows normal cell lines except for the platelets (may have mild anemia)&lt;br /&gt;
&lt;br /&gt;
==Treatment==&lt;br /&gt;
=== Options  ===&lt;br /&gt;
&lt;br /&gt;
#Corticosteroids &lt;br /&gt;
##First-line in adults &lt;br /&gt;
##Prednisone 60-100 mg/d w/ taper after count reaches normal &lt;br /&gt;
##Methylprednisolone 30mg/kg/d IV x3d (for life-threatening bleeding)&lt;br /&gt;
#IVIG &lt;br /&gt;
##First-line in children &lt;br /&gt;
##1gm/kg/d x2d&lt;br /&gt;
#Anti-D (RhoGAM) &lt;br /&gt;
##Pt must be Rh+ for it to work&lt;br /&gt;
#Transfusion (platelets) &lt;br /&gt;
##Indicated for life-threatening bleeding &lt;br /&gt;
##Transfuse only following first dose of methylprednisolone or IVIG &lt;br /&gt;
###Holding transfusion until after first dose results in greater rise in plt count&lt;br /&gt;
#Estrogen (uterine bleeding) &lt;br /&gt;
#25mg IV x1&amp;lt;br&amp;gt;&amp;amp;nbsp;&amp;amp;nbsp;&amp;amp;nbsp;&amp;amp;nbsp;&amp;amp;nbsp;&amp;amp;nbsp;&amp;amp;nbsp;&amp;amp;nbsp;&amp;amp;nbsp;&amp;amp;nbsp;&amp;amp;nbsp;&amp;amp;nbsp;&amp;amp;nbsp;&lt;br /&gt;
&lt;br /&gt;
===Indications===&lt;br /&gt;
====Adults====&lt;br /&gt;
#Plt &amp;gt;30K and asymptomatic: Usually do not require treatment&lt;br /&gt;
#Plt count &amp;lt;30K: Prednisone&lt;br /&gt;
#Plt &amp;lt;50K AND bleeding: Prednisone&lt;br /&gt;
#Life-threatening bleeding&lt;br /&gt;
##IVIG, methylprednisolone, platelet transfusion&lt;br /&gt;
&lt;br /&gt;
====Children====&lt;br /&gt;
#Plt count &amp;gt;30K: Usually do not require treatment&lt;br /&gt;
#Plt count &amp;lt;20K + significant bleeding: IVIG&lt;br /&gt;
#Plt count &amp;lt;10K: IVIG&lt;br /&gt;
#Life-threatening bleeding&lt;br /&gt;
##IVIG, methylprednisolone, platelet transfusion&lt;br /&gt;
&lt;br /&gt;
==Disposition==&lt;br /&gt;
#Admit:&lt;br /&gt;
##Pts w/ plt count &amp;lt;20K or those who have significant mucous membrane bleeding&lt;br /&gt;
#Discharge:&lt;br /&gt;
##Plt counts &amp;gt;20K AND asymptomatic or have only minor petechiae&lt;br /&gt;
&lt;br /&gt;
==Complications==&lt;br /&gt;
#Rare; more common in elderly&lt;br /&gt;
##Intracerebral bleeding&lt;br /&gt;
##Severe GI bleeding&lt;br /&gt;
&lt;br /&gt;
==See Also==&lt;br /&gt;
[[ITP in Pregnancy]]&lt;br /&gt;
&lt;br /&gt;
==Source ==&lt;br /&gt;
*Tintinalli&lt;br /&gt;
*UpToDate&lt;br /&gt;
&lt;br /&gt;
[[Category:Heme/Onc]]&lt;/div&gt;</summary>
		<author><name>Epae</name></author>
	</entry>
	<entry>
		<id>https://wikem.org/w/index.php?title=Immune_thrombocytopenic_purpura&amp;diff=9681</id>
		<title>Immune thrombocytopenic purpura</title>
		<link rel="alternate" type="text/html" href="https://wikem.org/w/index.php?title=Immune_thrombocytopenic_purpura&amp;diff=9681"/>
		<updated>2012-05-13T00:28:50Z</updated>

		<summary type="html">&lt;p&gt;Epae: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;==Background==&lt;br /&gt;
*Acquired autoimmune disease resulting in destruction of platelets&lt;br /&gt;
*Because circulating plts are functional, life-threatening bleeding only once plt &amp;lt;10K&lt;br /&gt;
*Types&lt;br /&gt;
**Acute&lt;br /&gt;
***More common among younger children&lt;br /&gt;
***Affects men/women equally&lt;br /&gt;
***Resolves in 1-2mo&lt;br /&gt;
**Chronic&lt;br /&gt;
***Lasts &amp;gt;3mo&lt;br /&gt;
***More common in adults and women&lt;br /&gt;
***Rarely remits spontaneously or with tx&lt;br /&gt;
***More likely to have an ynderlying disease or autoimmune disorder (e.g. SLE)&lt;br /&gt;
&lt;br /&gt;
==Clinical Features==&lt;br /&gt;
*Petechiae&lt;br /&gt;
*Epistaxis, ginigival bleeding, menorrhagia&lt;br /&gt;
&lt;br /&gt;
==Diagnosis==&lt;br /&gt;
*Diagnosis of exclusion&lt;br /&gt;
**Must differentiate from chronic ITP, which suggests an underlying disorder&lt;br /&gt;
*CBC shows normal cell lines except for the platelets (may have mild anemia)&lt;br /&gt;
&lt;br /&gt;
==Treatment==&lt;br /&gt;
=== Options ===&lt;br /&gt;
&lt;br /&gt;
##Corticosteroids &lt;br /&gt;
###First-line in adults &lt;br /&gt;
###Prednisone 60-100 mg/d w/ taper after count reaches normal &lt;br /&gt;
###Methylprednisolone 30mg/kg/d IV x3d (for life-threatening bleeding)&lt;br /&gt;
##IVIG &lt;br /&gt;
###First-line in children &lt;br /&gt;
###1gm/kg/d x2d&lt;br /&gt;
##Anti-D (RhoGAM) &lt;br /&gt;
###Pt must be Rh+ for it to work&lt;br /&gt;
##Transfusion (platelets) &lt;br /&gt;
###Indicated for life-threatening bleeding &lt;br /&gt;
###Transfuse only following first dose of methylprednisolone or IVIG &lt;br /&gt;
####Holding transfusion until after first dose results in greater rise in plt count&lt;br /&gt;
##Estrogen (uterine bleeding) &lt;br /&gt;
###25mg IV x1&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&amp;amp;nbsp;&amp;amp;nbsp;&amp;amp;nbsp;&amp;amp;nbsp;&amp;amp;nbsp;&amp;amp;nbsp;&amp;amp;nbsp;&amp;amp;nbsp;&amp;amp;nbsp;&amp;amp;nbsp;&amp;amp;nbsp;&amp;amp;nbsp;&amp;amp;nbsp;&amp;amp;nbsp;6.&amp;amp;nbsp;&amp;amp;nbsp;&amp;amp;nbsp; Emergent splenectomy - uncontrolled/life threatening hemorrhage&lt;br /&gt;
&lt;br /&gt;
&amp;amp;nbsp;&amp;amp;nbsp;&amp;amp;nbsp;&amp;amp;nbsp;&amp;amp;nbsp;&amp;amp;nbsp;&amp;amp;nbsp;&amp;amp;nbsp;&amp;amp;nbsp;&amp;amp;nbsp;&amp;amp;nbsp;&amp;amp;nbsp;&amp;amp;nbsp;&amp;amp;nbsp;&amp;amp;nbsp;&amp;amp;nbsp;&amp;amp;nbsp;&amp;amp;nbsp;&amp;amp;nbsp;&amp;amp;nbsp;&amp;amp;nbsp;&amp;amp;nbsp;&amp;amp;nbsp;&amp;amp;nbsp; 1. after tranfusion, IVIG, and steroids&lt;br /&gt;
&lt;br /&gt;
===Indications===&lt;br /&gt;
====Adults====&lt;br /&gt;
#Plt &amp;gt;30K and asymptomatic: Usually do not require treatment&lt;br /&gt;
#Plt count &amp;lt;30K: Prednisone&lt;br /&gt;
#Plt &amp;lt;50K AND bleeding: Prednisone&lt;br /&gt;
#Life-threatening bleeding&lt;br /&gt;
##IVIG, methylprednisolone, platelet transfusion&lt;br /&gt;
&lt;br /&gt;
====Children====&lt;br /&gt;
#Plt count &amp;gt;30K: Usually do not require treatment&lt;br /&gt;
#Plt count &amp;lt;20K + significant bleeding: IVIG&lt;br /&gt;
#Plt count &amp;lt;10K: IVIG&lt;br /&gt;
#Life-threatening bleeding&lt;br /&gt;
##IVIG, methylprednisolone, platelet transfusion&lt;br /&gt;
&lt;br /&gt;
==Disposition==&lt;br /&gt;
#Admit:&lt;br /&gt;
##Pts w/ plt count &amp;lt;20K or those who have significant mucous membrane bleeding&lt;br /&gt;
#Discharge:&lt;br /&gt;
##Plt counts &amp;gt;20K AND asymptomatic or have only minor petechiae&lt;br /&gt;
&lt;br /&gt;
==Complications==&lt;br /&gt;
#Rare; more common in elderly&lt;br /&gt;
##Intracerebral bleeding&lt;br /&gt;
##Severe GI bleeding&lt;br /&gt;
&lt;br /&gt;
==See Also==&lt;br /&gt;
[[ITP in Pregnancy]]&lt;br /&gt;
&lt;br /&gt;
==Source ==&lt;br /&gt;
*Tintinalli&lt;br /&gt;
*UpToDate&lt;br /&gt;
&lt;br /&gt;
[[Category:Heme/Onc]]&lt;/div&gt;</summary>
		<author><name>Epae</name></author>
	</entry>
	<entry>
		<id>https://wikem.org/w/index.php?title=Pneumonia_(main)&amp;diff=9680</id>
		<title>Pneumonia (main)</title>
		<link rel="alternate" type="text/html" href="https://wikem.org/w/index.php?title=Pneumonia_(main)&amp;diff=9680"/>
		<updated>2012-05-12T18:04:23Z</updated>

		<summary type="html">&lt;p&gt;Epae: /* Unhealthy */&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;==Background==&lt;br /&gt;
3 questions:&lt;br /&gt;
# Does this pt have pneumonia?&lt;br /&gt;
# If yes, does this pt need to be admitted?&lt;br /&gt;
# If yes, admit to the ward or ICU? &lt;br /&gt;
&lt;br /&gt;
==Clinical Presentation==&lt;br /&gt;
*Fever, chills, pleuritic CP, productive cough&lt;br /&gt;
**Fever is seen in 80%&lt;br /&gt;
*Tachypnea&lt;br /&gt;
**Most sensitive sign in elderly &lt;br /&gt;
*Abdominal pain, N/V/diarrhea may be seen with Legionella infection&lt;br /&gt;
&lt;br /&gt;
==Work-Up==&lt;br /&gt;
#CXR&lt;br /&gt;
#CBC&lt;br /&gt;
#Chemistry &lt;br /&gt;
&lt;br /&gt;
If pt will be admitted:&lt;br /&gt;
# Blood cx (required if pt may require ICU during their course)&lt;br /&gt;
# Sputum staining&lt;br /&gt;
## If concern for particular organism&lt;br /&gt;
&lt;br /&gt;
==Health care–associated PNA risk factors==&lt;br /&gt;
#Pts hospitalized for 2 or more days w/in past 90d&lt;br /&gt;
#Nursing home/long-term care residents&lt;br /&gt;
#Pts receiving home IV abx&lt;br /&gt;
#Dialysis pts&lt;br /&gt;
#Pts receiving chronic wound care&lt;br /&gt;
#Pts receiving chemotherapy&lt;br /&gt;
#Immunocompromised pts&lt;br /&gt;
&lt;br /&gt;
==Pseudomonas risk factors==&lt;br /&gt;
# Alcoholism&lt;br /&gt;
# Immunosuppression (incl. steroids)&lt;br /&gt;
# Structural lung disease&lt;br /&gt;
# Malnutrition&lt;br /&gt;
# Recent abx&lt;br /&gt;
# Recent hospital stay &lt;br /&gt;
&lt;br /&gt;
==Treatment==&lt;br /&gt;
===Outpatient, community-acquired PNA===&lt;br /&gt;
====Healthy====&lt;br /&gt;
#Clarithromycin XL 1000mg PO QD x7d OR&lt;br /&gt;
#Azithromycin 500mg PO day 1, 250mg on days 2-5 OR&lt;br /&gt;
#Doxycycline 100mg BID x 10-14d (2nd line choice)&lt;br /&gt;
==== Unhealthy ====&lt;br /&gt;
&lt;br /&gt;
#Chronic heart, lung, liver, or renal disease; DM, alcholism, malignancy.&amp;amp;nbsp; Add&lt;br /&gt;
##Levofloxacin 750mg QD x5d OR &lt;br /&gt;
##Moxifloxacin 400mg QD x7-14d OR &lt;br /&gt;
##Amoxicillin-clavulanate 2g BID AND Azithromycin 500mg day 1, 250mg days 2-5 OR Doxy&lt;br /&gt;
##3rd generation cephalosporin AND Azithromycin or Doxy&lt;br /&gt;
&lt;br /&gt;
===Inpatient===&lt;br /&gt;
====Community-acquired PNA====&lt;br /&gt;
#Levofloxacin 750mg QD x5d OR&lt;br /&gt;
#Moxifloxacin 400mg QD x7-14d OR&lt;br /&gt;
#3rd generation cephalosporin AND azithromycin&lt;br /&gt;
====Health Care-associated PNA====&lt;br /&gt;
#3-drug regimen recommended&lt;br /&gt;
##(Cefepime 1-2gm q8-12h OR ceftazidime 2gm q8h) + cipro 400mg q8h + vanco 15mg/kg q12 OR&lt;br /&gt;
##Imipenem 500mg q6hr + cipro 400mg q8hr + vanco 15mg/kg q12 OR&lt;br /&gt;
##Piperacillin-tazobactam 4.5gm q6h + cipro 400mg q8h + vanco 15mg/kg q12 &lt;br /&gt;
&lt;br /&gt;
====ICU, low risk of pseudomonas====&lt;br /&gt;
#Ceftriaxone 1gm IV and Azithromycin 500mg IV OR&lt;br /&gt;
#Ceftriaxone 1gm IV and (moxifloxacin 400mg IV or levofloxacin 750mg IV)&lt;br /&gt;
#Penicillin allergy&lt;br /&gt;
##Moxi/levofloxacin and (aztreonam 1-2gm IV or clindamycin 600mg IV)&lt;br /&gt;
&lt;br /&gt;
====ICU, risk of pseudomonas====&lt;br /&gt;
# Cefipime, imipenem, OR piperacillin-tazobactam + IV cipro/levo&lt;br /&gt;
# Cefipime, imipenem, OR piperacillin-tazobactam + gent + azithromycin&lt;br /&gt;
# Cefipime, imipenem, OR piperacillin-tazobactam + gent + cipro/levo&lt;br /&gt;
&lt;br /&gt;
==Disposition==&lt;br /&gt;
See [[Pneumonia (Port Score)]]&lt;br /&gt;
&lt;br /&gt;
==See Also==&lt;br /&gt;
*[[Pneumonia (Pathogens)]]&lt;br /&gt;
*[[Pneumonia (Peds)]]&lt;br /&gt;
*[[Pneumonia (Port Score)]]&lt;br /&gt;
&lt;br /&gt;
==Source==&lt;br /&gt;
*UpToDate&lt;br /&gt;
&lt;br /&gt;
[[Category:ID]]&lt;br /&gt;
[[Category:Pulm]]&lt;/div&gt;</summary>
		<author><name>Epae</name></author>
	</entry>
	<entry>
		<id>https://wikem.org/w/index.php?title=Priapism&amp;diff=9669</id>
		<title>Priapism</title>
		<link rel="alternate" type="text/html" href="https://wikem.org/w/index.php?title=Priapism&amp;diff=9669"/>
		<updated>2012-05-07T04:49:43Z</updated>

		<summary type="html">&lt;p&gt;Epae: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;== Background ==&lt;br /&gt;
&lt;br /&gt;
*Prolonged, unwanted erection not a/w sexual stimulation &amp;amp;gt; 4h&amp;lt;br&amp;gt;&lt;br /&gt;
*May lead to erectile dysfunction and penile necrosis if untreated &lt;br /&gt;
*2 types: &lt;br /&gt;
**1. High-flow (nonischemic) &lt;br /&gt;
***AV fistula from trauma (lacerated cavernous artery shunts blood into cavernous bodies) &lt;br /&gt;
***Usually not painful &lt;br /&gt;
***Ischemia/impotence does not occur &lt;br /&gt;
**2. Low-flow (ischemic) &lt;br /&gt;
***Veno-occlusion causing pooling of deoxygenated blood in cavernous tissue &lt;br /&gt;
****A/w SCD, meds, trauma, leukemia, infection, spinal cord injury/cauda equin, hypercoag &lt;br /&gt;
***Painful &lt;br /&gt;
***Fibrotic change --&amp;amp;gt; impotence &lt;br /&gt;
&lt;br /&gt;
== Clinical Features ==&lt;br /&gt;
&lt;br /&gt;
*Erect corpus cavernosum &lt;br /&gt;
*Flacid glans and spongiosum&lt;br /&gt;
&lt;br /&gt;
== Work-Up ==&lt;br /&gt;
&lt;br /&gt;
#CBC&amp;amp;nbsp;&amp;amp;nbsp; (eval leukemia, sickle cell)&lt;br /&gt;
#type &amp;amp;amp; screen&amp;amp;nbsp;&amp;amp;nbsp;&amp;amp;nbsp; (may need to exchange transfuse)&lt;br /&gt;
#coags &lt;br /&gt;
#urinalysis/tox (etoh, marijuana, cocaine can cause priapism)&lt;br /&gt;
#abg from cavernosa (if hx unclear) hypoxic, hypercapneic, acidotic --&amp;amp;gt; low flow&lt;br /&gt;
#Ultrasound &lt;br /&gt;
##Can distinguish between high-flow and low-flow&lt;br /&gt;
&lt;br /&gt;
== DDx ==&lt;br /&gt;
&lt;br /&gt;
#Peyronie's Disease &lt;br /&gt;
#Urethral foreign body &lt;br /&gt;
#Penile surgical implant &lt;br /&gt;
#Erection from sexual arousal&lt;br /&gt;
&lt;br /&gt;
== Treatment ==&lt;br /&gt;
&lt;br /&gt;
#Morphine &lt;br /&gt;
#IV hydration (sickle cell) &lt;br /&gt;
#O2 (sickle cell) &lt;br /&gt;
#Transfusion (sickle cell) &lt;br /&gt;
#Urology consult (especially important with traumatic priapism) &lt;br /&gt;
#Aspiration/injection of corpus cavernosum &lt;br /&gt;
##Rarely beneficial after 48hr &lt;br /&gt;
##Penile nerve block (2 or 10 o'clock)&amp;lt;br&amp;gt;&lt;br /&gt;
##Aspirate 5cc of blood from corpus cavernosum (3 or 9 o'clock position of shaft) w/ 19ga needle &lt;br /&gt;
###Inject 1mL diluted phenylephrine (100-500mcg/mL) q3-5min until resolution or one hour (max 1000mcg)&lt;br /&gt;
&lt;br /&gt;
== Disposition ==&lt;br /&gt;
&lt;br /&gt;
#Admit if refractory to treatment &lt;br /&gt;
#May dispo home if treatment is successful with close f/u by urology&lt;br /&gt;
&lt;br /&gt;
== Source ==&lt;br /&gt;
&lt;br /&gt;
*Tintinalli &lt;br /&gt;
*UpToDate &lt;br /&gt;
*emedicine&lt;br /&gt;
&lt;br /&gt;
[[Category:GU]] [[Category:Procedures]]&lt;/div&gt;</summary>
		<author><name>Epae</name></author>
	</entry>
	<entry>
		<id>https://wikem.org/w/index.php?title=Carbon_monoxide_toxicity&amp;diff=9522</id>
		<title>Carbon monoxide toxicity</title>
		<link rel="alternate" type="text/html" href="https://wikem.org/w/index.php?title=Carbon_monoxide_toxicity&amp;diff=9522"/>
		<updated>2012-04-21T23:35:30Z</updated>

		<summary type="html">&lt;p&gt;Epae: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;== Background ==&lt;br /&gt;
&lt;br /&gt;
#Colorless, odorless gas &lt;br /&gt;
#Most toxic component in smoke inhalation and major contributor to fire-related deaths &lt;br /&gt;
##Can co-occur with [[Cyanide]] toxicity in industrial fires &lt;br /&gt;
#Sources &lt;br /&gt;
##Automotive exhaust &lt;br /&gt;
##Propane-fueled heaters &lt;br /&gt;
##Wood or coal-burning heaters &lt;br /&gt;
##Structure fires &lt;br /&gt;
##Gasoline-powered motors &lt;br /&gt;
##Natural gas-powered heaters &lt;br /&gt;
#Peak incidence in winter months&lt;br /&gt;
&lt;br /&gt;
== Pathophysiology ==&lt;br /&gt;
&lt;br /&gt;
#Hypoxia &lt;br /&gt;
##Binding affinity of Hb for CO (carboxyhemoglobin) is 200x that of O2 &lt;br /&gt;
##Half-Life &lt;br /&gt;
###Room air: ~5hrs &lt;br /&gt;
###100% O2: ~1hr &lt;br /&gt;
###HBO 2.5atm: 24min &lt;br /&gt;
#Lactic acidosis &lt;br /&gt;
##CO inhibits oxidative phosphorylation &lt;br /&gt;
#Hypotension &lt;br /&gt;
##CO induces NO2 and guanylate cyclase release --&amp;amp;gt; vasodilation release&lt;br /&gt;
&lt;br /&gt;
== Workup ==&lt;br /&gt;
&lt;br /&gt;
#VBG &lt;br /&gt;
##Co-oximetry analysis will provide carboxyhemoglobin level &lt;br /&gt;
#Lactate &lt;br /&gt;
#Chemistry &lt;br /&gt;
#Troponin &lt;br /&gt;
#Total CK (rhabdo) &lt;br /&gt;
#ECG &lt;br /&gt;
##May range from normal to STEMI&amp;amp;nbsp;(most common ST, then prolonged QT)&lt;br /&gt;
###Few of the pts w/ AMI from CO have occlusive lesions in their arteries &lt;br /&gt;
#?Head CT &lt;br /&gt;
##May show b/l globus pallidus lesions in severe cases&lt;br /&gt;
&lt;br /&gt;
== Clinical Features ==&lt;br /&gt;
&lt;br /&gt;
#May range from &amp;quot;flu-like&amp;quot; symptoms to coma &lt;br /&gt;
#CNS &lt;br /&gt;
##Headache &lt;br /&gt;
##Visual disturbances &lt;br /&gt;
##Confusion &lt;br /&gt;
##Ataxia &lt;br /&gt;
##Seizure &lt;br /&gt;
##Syncope &lt;br /&gt;
##Retinal hemorrhage &lt;br /&gt;
##Focal neurologic deficit &lt;br /&gt;
#GI &lt;br /&gt;
##Vomiting &lt;br /&gt;
#Pulm &lt;br /&gt;
##Dyspnea/tachypnea &lt;br /&gt;
#Cardio &lt;br /&gt;
##Chest pain &lt;br /&gt;
##ECG changes/dysrhythmias &lt;br /&gt;
#Derm &lt;br /&gt;
##Bullous skin lesions &lt;br /&gt;
##Classic finding of cherry red oral mucosa is rarely seen in living pts&lt;br /&gt;
&lt;br /&gt;
== Diagnosis ==&lt;br /&gt;
&lt;br /&gt;
#Must have high clinical suspicion (esp in pts w/ coma, AMS, or anion gap acidosis) &lt;br /&gt;
##Comatose pt removed from fire should be assumed to have CO poisoning &lt;br /&gt;
#Carboxyhemoglobin Level &lt;br /&gt;
##Interpretation must take into account time since exposure and O2 tx &lt;br /&gt;
##Normal value in non-smokers is ~1%, normal value in smokers may be up to 10% &lt;br /&gt;
##Symptoms and COHb levels do not always correlate well &lt;br /&gt;
#Pulse oximetry is unreliable &lt;br /&gt;
##CoHb registers the same as O2Hb so will have artificially high SpO2 &lt;br /&gt;
##O2 saturation gap reflects discordance of SpO2 by pulse oximeter vs by VBG&lt;br /&gt;
&lt;br /&gt;
== Treatment ==&lt;br /&gt;
&lt;br /&gt;
#O2 100% by NRB or ETT &lt;br /&gt;
##Provide O2 until COHb value &amp;amp;lt;10% &lt;br /&gt;
#Hyperbaric Therapy (HBO) &lt;br /&gt;
##Decision to initiate HBO should be made in consultation w/ hyperbaric specialist &lt;br /&gt;
##Controversial who exactly benefits from tx &lt;br /&gt;
##Pt must be stable prior to transport &lt;br /&gt;
##Indications (generally accepted guidelines): &lt;br /&gt;
###Syncope &lt;br /&gt;
###Confusion/AMS &lt;br /&gt;
###Seizure &lt;br /&gt;
###Coma &lt;br /&gt;
###Focal neuro deficit &lt;br /&gt;
###Pregnancy w/ CoHb level &amp;amp;gt;15% &lt;br /&gt;
###Blood level &amp;amp;gt;25% &lt;br /&gt;
###Acute myocardial ischemia&lt;br /&gt;
&lt;br /&gt;
== Disposition ==&lt;br /&gt;
&lt;br /&gt;
#Minimal or no symptoms &lt;br /&gt;
##Discharge &lt;br /&gt;
#Mildly symptomatic &lt;br /&gt;
##Headache, vomiting, elevated COHb level &lt;br /&gt;
##Discharge after 4hr obs and symptom resolution &lt;br /&gt;
#Severely symptomatic &lt;br /&gt;
##Ataxia, syncope, chest pain, neuro deficit, dyspnea, ECG changes, pregnant w/ COHb &amp;amp;gt;15% &lt;br /&gt;
##Admit; discuss with hyperbaric specialist&lt;br /&gt;
&lt;br /&gt;
== Source ==&lt;br /&gt;
&lt;br /&gt;
Tintinalli &lt;br /&gt;
&lt;br /&gt;
[[Category:Tox]]&lt;/div&gt;</summary>
		<author><name>Epae</name></author>
	</entry>
</feed>